Big Pharma Split Corp Class A (PRM) — Tangible Net Worth Ratio
Big Pharma Split Corp Class A (PRM) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets (CA$0.00) from net assets (CA$18.27 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Big Pharma Split Corp Class A to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Big Pharma Split Corp Class A Tangible Net Worth Ratio (2017–2025)
This chart shows how Big Pharma Split Corp Class A's Tangible Net Worth Ratio has changed across 9 annual periods from 2017 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of CA$18.27 Million with intangible assets of CA$0.00 CAD. For live market cap and overall valuation, see Big Pharma Split Corp Class A stock valuation.
Annual Tangible Net Worth Ratio for Big Pharma Split Corp Class A (2017–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Big Pharma Split Corp Class A from 2017 to 2025, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Big Pharma Split Corp Class A capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CAD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | CA$18.27 Million | CA$0.00 | CA$31.84 Million | ▲ +0.0 pp |
| 2024 | 100.0% | CA$13.68 Million | CA$0.00 | CA$26.30 Million | ▲ +0.0 pp |
| 2023 | 100.0% | CA$15.85 Million | CA$0.00 | CA$26.53 Million | ▲ +0.0 pp |
| 2022 | 100.0% | CA$19.73 Million | CA$0.00 | CA$39.10 Million | ▲ +0.0 pp |
| 2021 | 100.0% | CA$22.40 Million | CA$0.00 | CA$37.81 Million | ▲ +0.0 pp |
| 2020 | 100.0% | CA$13.19 Million | CA$0.00 | CA$22.93 Million | ▲ +0.0 pp |
| 2019 | 100.0% | CA$16.31 Million | CA$0.00 | CA$27.18 Million | ▲ +0.0 pp |
| 2018 | 100.0% | CA$18.84 Million | CA$0.00 | CA$33.63 Million | ▲ +0.0 pp |
| 2017 | 100.0% | CA$18.68 Million | CA$0.00 | CA$32.49 Million | — |